$ cat molecule-index.md
# Molecule Index
> Same ingredient. Different brand. Different country. Different price.
Source-backed medicine price notes for the drugs we can verify now; ingredient-first index for the rest.
Mineral Oil, Petro o--o \/ /\ o--o
:| molecule · DailyMed SPL index
0.25 % Phenylephrine Hcl Hemorrhoidal
Mineral Oil, Petrolatum, Phenylephrine Hydrochloride · Oral
Mineral Oil, Petro o--o \/ /\ o--o
:| molecule · DailyMed SPL index
0.25 % Phenylephrine Hcl Hemorrhoidal
Mineral Oil, Petrolatum, Phenylephrine Hydrochloride · Oral
Lidocaine 4.00, Ph o--o \/ /\ o--o
:| molecule · DailyMed SPL index
Dr Butlers Hemorrhoid And Fissure Pf
Lidocaine 4.00, Phenylephrine Hydrochloride 0.25 · Oral
Phenylephrine Hydr o--o \/ /\ o--o
:| molecule · DailyMed SPL index
Dr. Butler Hemorrhoid Treatment
Phenylephrine Hydrochloride 0.25%, Witch Hazel 50% · Oral
Lidocaine 5%, Phen o--o \/ /\ o--o
:| molecule · DailyMed SPL index
Dch Rapid Relief Hemorrhoidal
Lidocaine 5%, Phenylephrine Hydrochloride 0.25% · Oral
Lidocaine 4%, Phen o--o \/ /\ o--o
:| molecule · DailyMed SPL index
Warrior Rectal Care
Lidocaine 4%, Phenylephrine Hydrochloride 0.25% · Oral
Lidocaine 5%, Phen o--o \/ /\ o--o
:| molecule · DailyMed SPL index
Zensa Numbing Gel
Lidocaine 5%, Phenylephrine Hydrochloride 0.25% · Oral
Lidocaine 4.00, Ph o--o \/ /\ o--o
:| molecule · DailyMed SPL index
Hemorrhoidal- Ointment
Lidocaine 4.00, Phenylephrine Hydrochloride 0.25 · Oral
Phenylephrine Hydr o--o \/ /\ o--o
:| molecule · DailyMed SPL index
Nasal Decongestant Rhinall / Drops
Phenylephrine Hydrochloride 0.25 · Oral
Phenylephrine Hydr o--o \/ /\ o--o
:| molecule · DailyMed SPL index
Nasal Decongestant Rhinall
Phenylephrine Hydrochloride 0.25 · Oral
$ cat method.md
Ingredient first, prices second
Now
Index 100,000 drug/package records by active ingredient, brand, route, class hint, source, and risk/price-gap watch signals.
Next
Attach daily country snapshots for US, Canada, UK, India, Mexico, and EU comparator markets.
Later
Track pharmacy-level prices, coupons, cash-pay providers, generic availability, and verified substitution boundaries.